The plan lists six anti-influenza drugs available in China, including oseltamivir, peramivir and zanamivir. It adds marbaloxavir and favipiravir while removing amantadine and rimantadine.
The Department of Justice says it will "vigorously defend" Donald Trump's executive order ending birthright citizenship, after it was temporarily blocked in a federal court earlier today.